Australia markets open in 6 hours 10 minutes

Vistagen Therapeutics, Inc. (VTGN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.3297-0.0503 (-1.15%)
As of 01:49PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
1,042
-227.3
1,109
1,090
0
Operating expenses
Research development
21,923
44,377
35,408
11,926
13,374
Selling general and administrative
13,021
14,664
13,248
7,098
6,600
Total operating expenses
34,944
59,041
48,656
19,024
19,974
Operating income or loss
-33,901
-59,268
-47,547
-17,934
-19,974
Interest expense
-
23
0
13
15
Total other income/expenses net
-
-
-232
0.6
-827
Income before tax
-32,065
-59,242
-47,759
-17,932
-20,771
Income tax expense
2.9
5.9
3.4
2.6
2.6
Income from continuing operations
-32,068
-59,248
-47,762
-17,934
-20,774
Net income
-32,068
-59,248
-47,762
-17,934
-20,774
Net income available to common shareholders
-32,068
-59,248
-48,707
-42,320
-22,038
Basic EPS
-4.65
-8.51
-7.38
-14.70
-15.00
Diluted EPS
-4.65
-8.51
-7.38
-14.70
-15.00
Basic average shares
7,873
6,959
6,600
2,871
1,462
Diluted average shares
7,873
6,959
6,600
2,871
1,462